| Literature DB >> 32366885 |
Lavanya Kalaimani1,2, Bharanidharan Devarajan3, Umadevi Subramanian3, Vanniarajan Ayyasamy4, Venkatesh Prajna Namperumalsamy5, Muthukkaruppan Veerappan1, Gowri Priya Chidambaranathan6,7.
Abstract
The objective of the study was to elucidate the microRNA (miRNA) profile of an enriched human corneal epithelial stem cell (CESC) population in comparison to differentiated central corneal epithelial cells (CCECs) by small RNA sequencing. The CESCs were enriched by differential enzymatic treatment to isolate the basal limbal epithelial cells followed by laser capture microdissection of cells with nucleus to cytoplasm ratio ≥0.7, from donor tissues. Small RNA sequencing was carried out using Illumina NextSeq. 500 platform and the validation of differentially expressed miRNAs by quantitative real-time PCR (qPCR) and locked nucleic acid miRNA in-situ hybridization (LNA-ISH). The sequencing identified 62 miRNAs in CESCs and 611 in CCECs. Six miRNAs: hsa-miR-21-5p, 3168, 143-3p, 10a-5p, 150-5p and 1910-5p were found to be significantly upregulated in enriched CESCs, which was further confirmed by qPCR and LNA-ISH. The expression of hsa-miR-143-3p was exclusive to clusters of limbal basal epithelial cells. The targets of the upregulated miRNAs were predicted to be associated with signaling pathways -Wnt, PI3K-AKT, MAPK and pathways that regulate pluripotency of stem cells, cell migration, growth and proliferation. Further studies are essential to elucidate their functional role in maintenance of stemness. The findings of the study also hypothesize the inherent potential of hsa-miR-143-3p to serve as a biomarker for identifying CESCs.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32366885 PMCID: PMC7198595 DOI: 10.1038/s41598-020-64273-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Volcano plot showing differentially expressed miRNAs in CESCs and CCECs. M-D values in noise are represented by black dots, and miRNAs with p-value ≤ 0.9 by red dots. M –value (Mean fold change): log2(x1/x2). D –value (Difference in expression levels): |x1-x2 | . where x1 represents the expression level in CESCs and x2 in CCECs.
Figure 2MicroRNAs with high read counts in corneal epithelial stem cells and central corneal epithelial cells by small RNA sequencing. (a) Bar diagram showing the top ten miRNAs expressed in enriched CESCs based on raw read counts. (b) Bar diagram showing the top ten miRNAs expressed in CCECs based on raw read counts.
Differentially expressed miRNAs CESCs vs. CCECs validated by qPCR.
| miRNA | NGS fold change | qPCR fold change |
|---|---|---|
| hsa-miR-21-5p | 11 | 7.34 ± 0.38 |
| hsa-miR-3168 | 10 | 3.71 ± 0.72 |
| hsa-miR-143-3p | 10 | 76.44 ± 3.07 |
| hsa-miR-150-5p | 7 | 13.86 ± 1.49 |
| hsa-miR-1910-5p | 8 | 7.76 ± 0.17 |
| hsa-miR-10a-5p | 8 | 11.76 ± 0.75 |
| hsa-miR-181a-5p | −12 | −894 ± 83.22 |
| hsa-miR-184 | −15 | −2409 ± 214.9 |
| hsa-let-7a-5p | −5 | −1.66 ± 0.062 |
| hsa-let-7b-5p | −10 | −1.98 ± 0.11 |
| hsa-miR-205-5p | −11 | −14.64 ± 0.39 |
| hsa-miR-204-5p | −11 | −2.18 ± 0.08 |
| hsa-miR-4485-3p | −9 | −10.63 ± 1.21 |
| hsa-miR-92a-3p | −2 | −5.47 ± 0.16 |
| hsa-miR-191-5p | NS | 1.10 ± 0.02 |
| hsa-miR-26a-5p | NS | 1.99 ± 0.11 |
NS-not significant.
Figure 3Quantitative Real time PCR validation of differentially expressed miRNAs. Relative miRNA expression (RQ) in (a) miRNAs highly expressed in CESCs in comparison to CCECs and (b) miRNAs highly expressed in CCECs in comparison to CESCs by qPCR using SYBR Green chemistry. Each sample (n = 3) was run in triplicate. The data were expressed as mean ± SEM and relative fold change of expression (RQ) was calculated by 2-∆∆CT method after normalization with RNU6B (Reference microRNA). (**P < 0.01; ***P < 0.001; NS P > 0.05; Mann–Whitney U test).
Figure 4Locked nucleic acid in-situ hybridization of miRNAs highly expressed in CESCs. Expression of hsa-miR-21-5p, hsa-miR-3168 and hsa-miR-10a-5p (green) was higher in clusters of limbal basal epithelial cells compared to corneal epithelial cells, while the expression of hsa-miR-143–3p was restricted to clusters of cells in the limbal basal epithelium. Expression of hsa-miR-150-5p was evident in all layers of limbal epithelium however highly prominent in a few clusters in basal layer. Hsa-miR-1910-5p had discontinuous positivity in limbal basal epithelial layer, while hsa-miR-26a-5p had equal expression in the basal layer both limbal and corneal epithelium. Nuclei were stained with propidium iodide (PI, red). Positive control RNU6B was detected in all layers of epithelium both in limbus and cornea, whereas no signal was detected when hybridized with scrambled sequence. Asterisks represent the positivity in clusters. The dotted line demarcates the termination of the epithelium and beginning of the underlying stroma. Scale bar: 50 µm.
Figure 5Network of differentially expressed miRNAs between CESCs and CCECs, their target genes and the stemness related pathways associated with them. Nodes red in colour are the miRNAs, blue are genes and green are their associated pathways.
List of direct targets of selected miRNAs highly expressed in CESCs and their functional role.
| miRNA | Targets | Functional role | Reference |
|---|---|---|---|
| Hsa-miR-143-3p | Inhibits adipocyte proliferation and enhance their differentiation | [ | |
| Inhibits proliferation, cell migration and invasion of breast cancer | [ | ||
| Suppresses colorectal cancer cell growth | [ | ||
| Regulates cell proliferation and apoptosis | [ | ||
| Regulation of myogenesis | [ | ||
| Down regulation promotes propagation, migration, epithelial mesenchymal transition and stem cell phenotype of renal canal cells | [ | ||
| Hsa-miR-21-5p | Crucial for neuronal function | [ | |
| Hsa-miR-10a-5p | Tumor suppressor | [ | |
| Hsa-miR-150-5p | Decrease migration, invasion and angiogenesis in Rheumatoid arthritis | [ | |
| A novel Wnt effector that may enhance epithelial mesenchymal transition of colorectal cancer cells | [ | ||
| Inhibits proliferation and tumorigenicity via retarding G1/S phase transition | [ | ||
| Promotes proliferation of lung cancer cells | [ |